You are here: Home » Current Affairs » Coronavirus » News
Cipla open to forge a partnership to distribute Covid-19 vaccines in India
Business Standard

Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech

Vaccine effective against all emerging coronavirus variants, says study

Topics
Bharat Biotech | Coronavirus Vaccine | Vaccination

Sohini Das  |  Mumbai 



Bharat Biotech supplied 20 million doses to the “national roll-out” in April
Bharat Biotech supplied 20 million doses to the “national roll-out” in April

Hyderabad-based maker in April expanded its Covaxin-manufacturing capacity to 500 million doses a year, the company said on Sunday.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, May 17 2021. 00:12 IST

RECOMMENDED FOR YOU